| 1 | waiting | 1,941 |
| 2 | terminal | 1,635 |
| 3 | heterozygous | 1,090 |
| 4 | homozygous | 974 |
| 5 | wait | 485 |
| 6 | drug-free | 195 |
| 7 | heterozygote | 90 |
| 8 | homozygote | 87 |
| 9 | 1-cm | 50 |
| 10 | 3-cm | 45 |
| 11 | 2-cm | 42 |
| 12 | hemizygous | 41 |
| 13 | snoezelen | 40 |
| 14 | b1b1 | 29 |
| 15 | trinucleotide | 19 |
| 16 | hypomorphic | 16 |
| 17 | hmz | 13 |
| 18 | defect-free | 11 |
| 19 | electron-poor | 11 |
| 20 | homozygotic | 10 |
| 21 | kiupel | 10 |
| 22 | low-expression | 10 |
| 23 | radner | 10 |
| 24 | centriole | 9 |
| 25 | glucocorticoid-resistant | 9 |
| 26 | phosphomimetic | 9 |
| 27 | ptv2 | 9 |
| 28 | avaii | 8 |
| 29 | e/d | 8 |
| 30 | low-stress | 8 |
| 31 | 'waiting | 7 |
| 32 | crane | 7 |
| 33 | co-eluting | 6 |
| 34 | deaerated | 6 |
| 35 | gap-free | 6 |
| 36 | inked | 6 |
| 37 | multi-copy | 6 |
| 38 | tetrahydrobiopterin-responsive | 6 |
| 39 | adra2b | 5 |
| 40 | cell-cycle-dependent | 5 |
| 41 | ctv-ptv | 5 |
| 42 | gel-coated | 5 |
| 43 | gstm1/gstt1 | 5 |
| 44 | heterozygotic | 5 |
| 45 | myofilament-negative | 5 |
| 46 | myofilament-positive | 5 |
| 47 | proestrous | 5 |
| 48 | rasping | 5 |
| 49 | attil | 4 |
| 50 | g380r | 4 |
| 51 | nonisotopic | 4 |
| 52 | post-adjuvant | 4 |
| 53 | treatment/wait | 4 |
| 54 | 2-bp | 3 |
| 55 | alad1-2/2-2 | 3 |
| 56 | ci-type | 3 |
| 57 | coherex | 3 |
| 58 | colposcopy-diagnosed | 3 |
| 59 | d202n | 3 |
| 60 | deltactb3 | 3 |
| 61 | dentin/cementum | 3 |
| 62 | gln27gln | 3 |
| 63 | h2/h2 | 3 |
| 64 | low-risk/intermediate-1-risk | 3 |
| 65 | non-apoe4 | 3 |
| 66 | non-inherited | 3 |
| 67 | normally-dimensioned | 3 |
| 68 | poly-course | 3 |
| 69 | secb | 3 |
| 70 | talairach | 3 |
| 71 | top-five | 3 |
| 72 | treatment/waiting | 3 |
| 73 | tumor-involved | 3 |
| 74 | xl-499 | 3 |
| 75 | 'shopping | 2 |
| 76 | 5-asa-treated | 2 |
| 77 | 6,766 | 2 |
| 78 | 7-letter | 2 |
| 79 | alad1-1 | 2 |
| 80 | alpha-cardiac | 2 |
| 81 | anthracycline/taxane-pretreated | 2 |
| 82 | body-conforming | 2 |
| 83 | brca1-gene | 2 |
| 84 | capsaicin-desensitized | 2 |
| 85 | core-promoter | 2 |
| 86 | cytokine-pretreated | 2 |
| 87 | early-symptomatic | 2 |
| 88 | egfr-sensitive | 2 |
| 89 | enzymun-test | 2 |
| 90 | first-encounter | 2 |
| 91 | genotype-confirmed | 2 |
| 92 | gtv-ptv | 2 |
| 93 | guanine-adenine-adenine | 2 |
| 94 | her2-nonamplified | 2 |
| 95 | high/average | 2 |
| 96 | ins/ins | 2 |
| 97 | k650e | 2 |
| 98 | mcnpx | 2 |
| 99 | me3 | 2 |
| 100 | non-muscular | 2 |
| 101 | non-sclerotic | 2 |
| 102 | phospho-mimicking | 2 |
| 103 | post-waiting | 2 |
| 104 | prohibitive-risk | 2 |
| 105 | renal-limited | 2 |
| 106 | sod-1-mediated | 2 |
| 107 | tecdf | 2 |
| 108 | thymine-dna | 2 |
| 109 | tobacco-deprived | 2 |
| 110 | unreleased | 2 |
| 111 | 'non-renal | 1 |
| 112 | -cycloart-24-en-3β,22,26-triol | 1 |
| 113 | -muscle | 1 |
| 114 | 0266 | 1 |
| 115 | 1.26-9 | 1 |
| 116 | 1.3-87 | 1 |
| 117 | 1.3–2.8 | 1 |
| 118 | 1.4-2 | 1 |
| 119 | 1.6-15 | 1 |
| 120 | 1.8kbp | 1 |
| 121 | 10-percentage-point | 1 |
| 122 | 10.6-h | 1 |
| 123 | 12.2-mb | 1 |
| 124 | 12.5-mb | 1 |
| 125 | 12.5-min | 1 |
| 126 | 13-bp | 1 |
| 127 | 14.5-day | 1 |
| 128 | 15-nucleotide | 1 |
| 129 | 15q26.2→qter | 1 |
| 130 | 1·7-1·8 | 1 |
| 131 | 2-volume | 1 |
| 132 | 2.6-4.3 | 1 |
| 133 | 2.76mb | 1 |
| 134 | 22q13 | 1 |
| 135 | 25.8-day | 1 |
| 136 | 3.17-mb | 1 |
| 137 | 4.0-6.4 | 1 |
| 138 | 5-bromo-2-deoxyuridine/terminal | 1 |
| 139 | 51-week-old | 1 |
| 140 | 6-mb | 1 |
| 141 | 6a-g-g | 1 |
| 142 | 72-nucleotide | 1 |
| 143 | 894gg | 1 |
| 144 | 9.04-mb | 1 |
| 145 | 9.29-mb | 1 |
| 146 | 9c-induced | 1 |
| 147 | acaulescent | 1 |
| 148 | acid-accumulating | 1 |
| 149 | ag551d | 1 |
| 150 | apoe-4/4 | 1 |
| 151 | azole-bridged | 1 |
| 152 | bank-classified | 1 |
| 153 | banned-substance | 1 |
| 154 | bmimcl-impregnated | 1 |
| 155 | brachymyrmex | 1 |
| 156 | brain-wide | 1 |
| 157 | brassicaceae-specific | 1 |
| 158 | cancer-negative | 1 |
| 159 | cardiomyocyte-restricted | 1 |
| 160 | caulescent | 1 |
| 161 | cbt/waiting | 1 |
| 162 | cementodentinal | 1 |
| 163 | cementum/dentine | 1 |
| 164 | charge-reversal | 1 |
| 165 | chemoantibiotical | 1 |
| 166 | close/positive | 1 |
| 167 | coagulation-monitoring | 1 |
| 168 | consultation/treatment | 1 |
| 169 | controlled-temperature | 1 |
| 170 | cytarabine-refractory | 1 |
| 171 | deacetylation-mimetic | 1 |
| 172 | diffusion-sensitised | 1 |
| 173 | dna-test-verified | 1 |
| 174 | drm-causing | 1 |
| 175 | emerinopathy | 1 |
| 176 | epifisa | 1 |
| 177 | f2/f3 | 1 |
| 178 | f788c | 1 |
| 179 | fibropolycystic | 1 |
| 180 | formamidopyrimidine-dna | 1 |
| 181 | formononetin-treated | 1 |
| 182 | formularly | 1 |
| 183 | françois-victor | 1 |
| 184 | glu180gly | 1 |
| 185 | glu526val | 1 |
| 186 | gmfad8-1 | 1 |
| 187 | group,5 | 1 |
| 188 | gsta1-1/a2-2 | 1 |
| 189 | her2-positive/hr-positive | 1 |
| 190 | heterozygousity | 1 |
| 191 | hetrozygous | 1 |
| 192 | hla-dr1 | 1 |
| 193 | hpv16+ | 1 |
| 194 | individual-varying | 1 |
| 195 | l461p | 1 |
| 196 | laco | 1 |
| 197 | late-talking | 1 |
| 198 | low-/int-1-risk | 1 |
| 199 | luminal-basal | 1 |
| 200 | lys/arg | 1 |
| 201 | manured | 1 |
| 202 | methide-derived | 1 |
| 203 | methylthio-containing | 1 |
| 204 | mis-sense | 1 |
| 205 | mixing/placement | 1 |
| 206 | mlv-induced | 1 |
| 207 | mutation-causing | 1 |
| 208 | n-heptyl | 1 |
| 209 | n/f-mutated | 1 |
| 210 | n596del | 1 |
| 211 | neopetrosia | 1 |
| 212 | nine-base | 1 |
| 213 | non-ligatable | 1 |
| 214 | non-lof | 1 |
| 215 | non-t-allele | 1 |
| 216 | nonmicroalbuminuric | 1 |
| 217 | nonrelapsing | 1 |
| 218 | nonsens | 1 |
| 219 | odor-baited | 1 |
| 220 | one-base | 1 |
| 221 | p.a87_g92del | 1 |
| 222 | p.tyr859his | 1 |
| 223 | p453t | 1 |
| 224 | pancreatic-insufficient | 1 |
| 225 | papionin | 1 |
| 226 | paternal-origin | 1 |
| 227 | phenotype-negative | 1 |
| 228 | posteromedian | 1 |
| 229 | prevalent/incident | 1 |
| 230 | q61h | 1 |
| 231 | quasi-comprehensive | 1 |
| 232 | question-prompt | 1 |
| 233 | r-carrier | 1 |
| 234 | randomly-generated | 1 |
| 235 | rapid-breakdown | 1 |
| 236 | rccr | 1 |
| 237 | red-fluorescent-positive | 1 |
| 238 | rochester-based | 1 |
| 239 | runx1-mutated | 1 |
| 240 | s727a | 1 |
| 241 | sandcrete | 1 |
| 242 | sdrm | 1 |
| 243 | separation-related | 1 |
| 244 | serotype-respiratory | 1 |
| 245 | shown.t1 | 1 |
| 246 | single-amino-acid | 1 |
| 247 | sod1-linked | 1 |
| 248 | sod1-mediated | 1 |
| 249 | sod1-related | 1 |
| 250 | space-heated | 1 |
| 251 | superior-to-inferior | 1 |
| 252 | t613m | 1 |
| 253 | teminal | 1 |
| 254 | tesla/meter | 1 |
| 255 | three-solvent | 1 |
| 256 | tljn-treated | 1 |
| 257 | to-do | 1 |
| 258 | trfm/legs | 1 |
| 259 | trp225cys | 1 |
| 260 | ureteroureteral | 1 |
| 261 | uro-check | 1 |
| 262 | v-leiden | 1 |
| 263 | v210i | 1 |
| 264 | vcug-documented | 1 |
| 265 | vg-treated | 1 |
| 266 | ~2-4 | 1 |
| 267 | ~5.7 | 1 |
| 268 | ±5-point | 1 |
| 269 | δrpos | 1 |
| 270 | ∼200-h | 1 |
| 1 | 'non-renal | 1 |
| 2 | 'shopping | 2 |
| 3 | 'waiting | 7 |
| 4 | -cycloart-24-en-3β,22,26-triol | 1 |
| 5 | -muscle | 1 |
| 6 | 0266 | 1 |
| 7 | 1-cm | 50 |
| 8 | 1.26-9 | 1 |
| 9 | 1.3-87 | 1 |
| 10 | 1.3–2.8 | 1 |
| 11 | 1.4-2 | 1 |
| 12 | 1.6-15 | 1 |
| 13 | 1.8kbp | 1 |
| 14 | 10-percentage-point | 1 |
| 15 | 10.6-h | 1 |
| 16 | 12.2-mb | 1 |
| 17 | 12.5-mb | 1 |
| 18 | 12.5-min | 1 |
| 19 | 13-bp | 1 |
| 20 | 14.5-day | 1 |
| 21 | 15-nucleotide | 1 |
| 22 | 15q26.2→qter | 1 |
| 23 | 1·7-1·8 | 1 |
| 24 | 2-bp | 3 |
| 25 | 2-cm | 42 |
| 26 | 2-volume | 1 |
| 27 | 2.6-4.3 | 1 |
| 28 | 2.76mb | 1 |
| 29 | 22q13 | 1 |
| 30 | 25.8-day | 1 |
| 31 | 3-cm | 45 |
| 32 | 3.17-mb | 1 |
| 33 | 4.0-6.4 | 1 |
| 34 | 5-asa-treated | 2 |
| 35 | 5-bromo-2-deoxyuridine/terminal | 1 |
| 36 | 51-week-old | 1 |
| 37 | 6,766 | 2 |
| 38 | 6-mb | 1 |
| 39 | 6a-g-g | 1 |
| 40 | 7-letter | 2 |
| 41 | 72-nucleotide | 1 |
| 42 | 894gg | 1 |
| 43 | 9.04-mb | 1 |
| 44 | 9.29-mb | 1 |
| 45 | 9c-induced | 1 |
| 46 | acaulescent | 1 |
| 47 | acid-accumulating | 1 |
| 48 | adra2b | 5 |
| 49 | ag551d | 1 |
| 50 | alad1-1 | 2 |
| 51 | alad1-2/2-2 | 3 |
| 52 | alpha-cardiac | 2 |
| 53 | anthracycline/taxane-pretreated | 2 |
| 54 | apoe-4/4 | 1 |
| 55 | attil | 4 |
| 56 | avaii | 8 |
| 57 | azole-bridged | 1 |
| 58 | b1b1 | 29 |
| 59 | bank-classified | 1 |
| 60 | banned-substance | 1 |
| 61 | bmimcl-impregnated | 1 |
| 62 | body-conforming | 2 |
| 63 | brachymyrmex | 1 |
| 64 | brain-wide | 1 |
| 65 | brassicaceae-specific | 1 |
| 66 | brca1-gene | 2 |
| 67 | cancer-negative | 1 |
| 68 | capsaicin-desensitized | 2 |
| 69 | cardiomyocyte-restricted | 1 |
| 70 | caulescent | 1 |
| 71 | cbt/waiting | 1 |
| 72 | cell-cycle-dependent | 5 |
| 73 | cementodentinal | 1 |
| 74 | cementum/dentine | 1 |
| 75 | centriole | 9 |
| 76 | charge-reversal | 1 |
| 77 | chemoantibiotical | 1 |
| 78 | ci-type | 3 |
| 79 | close/positive | 1 |
| 80 | co-eluting | 6 |
| 81 | coagulation-monitoring | 1 |
| 82 | coherex | 3 |
| 83 | colposcopy-diagnosed | 3 |
| 84 | consultation/treatment | 1 |
| 85 | controlled-temperature | 1 |
| 86 | core-promoter | 2 |
| 87 | crane | 7 |
| 88 | ctv-ptv | 5 |
| 89 | cytarabine-refractory | 1 |
| 90 | cytokine-pretreated | 2 |
| 91 | d202n | 3 |
| 92 | deacetylation-mimetic | 1 |
| 93 | deaerated | 6 |
| 94 | defect-free | 11 |
| 95 | deltactb3 | 3 |
| 96 | dentin/cementum | 3 |
| 97 | diffusion-sensitised | 1 |
| 98 | dna-test-verified | 1 |
| 99 | drm-causing | 1 |
| 100 | drug-free | 195 |
| 101 | e/d | 8 |
| 102 | early-symptomatic | 2 |
| 103 | egfr-sensitive | 2 |
| 104 | electron-poor | 11 |
| 105 | emerinopathy | 1 |
| 106 | enzymun-test | 2 |
| 107 | epifisa | 1 |
| 108 | f2/f3 | 1 |
| 109 | f788c | 1 |
| 110 | fibropolycystic | 1 |
| 111 | first-encounter | 2 |
| 112 | formamidopyrimidine-dna | 1 |
| 113 | formononetin-treated | 1 |
| 114 | formularly | 1 |
| 115 | françois-victor | 1 |
| 116 | g380r | 4 |
| 117 | gap-free | 6 |
| 118 | gel-coated | 5 |
| 119 | genotype-confirmed | 2 |
| 120 | gln27gln | 3 |
| 121 | glu180gly | 1 |
| 122 | glu526val | 1 |
| 123 | glucocorticoid-resistant | 9 |
| 124 | gmfad8-1 | 1 |
| 125 | group,5 | 1 |
| 126 | gsta1-1/a2-2 | 1 |
| 127 | gstm1/gstt1 | 5 |
| 128 | gtv-ptv | 2 |
| 129 | guanine-adenine-adenine | 2 |
| 130 | h2/h2 | 3 |
| 131 | hemizygous | 41 |
| 132 | her2-nonamplified | 2 |
| 133 | her2-positive/hr-positive | 1 |
| 134 | heterozygote | 90 |
| 135 | heterozygotic | 5 |
| 136 | heterozygous | 1,090 |
| 137 | heterozygousity | 1 |
| 138 | hetrozygous | 1 |
| 139 | high/average | 2 |
| 140 | hla-dr1 | 1 |
| 141 | hmz | 13 |
| 142 | homozygote | 87 |
| 143 | homozygotic | 10 |
| 144 | homozygous | 974 |
| 145 | hpv16+ | 1 |
| 146 | hypomorphic | 16 |
| 147 | individual-varying | 1 |
| 148 | inked | 6 |
| 149 | ins/ins | 2 |
| 150 | k650e | 2 |
| 151 | kiupel | 10 |
| 152 | l461p | 1 |
| 153 | laco | 1 |
| 154 | late-talking | 1 |
| 155 | low-/int-1-risk | 1 |
| 156 | low-expression | 10 |
| 157 | low-risk/intermediate-1-risk | 3 |
| 158 | low-stress | 8 |
| 159 | luminal-basal | 1 |
| 160 | lys/arg | 1 |
| 161 | manured | 1 |
| 162 | mcnpx | 2 |
| 163 | me3 | 2 |
| 164 | methide-derived | 1 |
| 165 | methylthio-containing | 1 |
| 166 | mis-sense | 1 |
| 167 | mixing/placement | 1 |
| 168 | mlv-induced | 1 |
| 169 | multi-copy | 6 |
| 170 | mutation-causing | 1 |
| 171 | myofilament-negative | 5 |
| 172 | myofilament-positive | 5 |
| 173 | n-heptyl | 1 |
| 174 | n/f-mutated | 1 |
| 175 | n596del | 1 |
| 176 | neopetrosia | 1 |
| 177 | nine-base | 1 |
| 178 | non-apoe4 | 3 |
| 179 | non-inherited | 3 |
| 180 | non-ligatable | 1 |
| 181 | non-lof | 1 |
| 182 | non-muscular | 2 |
| 183 | non-sclerotic | 2 |
| 184 | non-t-allele | 1 |
| 185 | nonisotopic | 4 |
| 186 | nonmicroalbuminuric | 1 |
| 187 | nonrelapsing | 1 |
| 188 | nonsens | 1 |
| 189 | normally-dimensioned | 3 |
| 190 | odor-baited | 1 |
| 191 | one-base | 1 |
| 192 | p.a87_g92del | 1 |
| 193 | p.tyr859his | 1 |
| 194 | p453t | 1 |
| 195 | pancreatic-insufficient | 1 |
| 196 | papionin | 1 |
| 197 | paternal-origin | 1 |
| 198 | phenotype-negative | 1 |
| 199 | phospho-mimicking | 2 |
| 200 | phosphomimetic | 9 |
| 201 | poly-course | 3 |
| 202 | post-adjuvant | 4 |
| 203 | post-waiting | 2 |
| 204 | posteromedian | 1 |
| 205 | prevalent/incident | 1 |
| 206 | proestrous | 5 |
| 207 | prohibitive-risk | 2 |
| 208 | ptv2 | 9 |
| 209 | q61h | 1 |
| 210 | quasi-comprehensive | 1 |
| 211 | question-prompt | 1 |
| 212 | r-carrier | 1 |
| 213 | radner | 10 |
| 214 | randomly-generated | 1 |
| 215 | rapid-breakdown | 1 |
| 216 | rasping | 5 |
| 217 | rccr | 1 |
| 218 | red-fluorescent-positive | 1 |
| 219 | renal-limited | 2 |
| 220 | rochester-based | 1 |
| 221 | runx1-mutated | 1 |
| 222 | s727a | 1 |
| 223 | sandcrete | 1 |
| 224 | sdrm | 1 |
| 225 | secb | 3 |
| 226 | separation-related | 1 |
| 227 | serotype-respiratory | 1 |
| 228 | shown.t1 | 1 |
| 229 | single-amino-acid | 1 |
| 230 | snoezelen | 40 |
| 231 | sod-1-mediated | 2 |
| 232 | sod1-linked | 1 |
| 233 | sod1-mediated | 1 |
| 234 | sod1-related | 1 |
| 235 | space-heated | 1 |
| 236 | superior-to-inferior | 1 |
| 237 | t613m | 1 |
| 238 | talairach | 3 |
| 239 | tecdf | 2 |
| 240 | teminal | 1 |
| 241 | terminal | 1,635 |
| 242 | tesla/meter | 1 |
| 243 | tetrahydrobiopterin-responsive | 6 |
| 244 | three-solvent | 1 |
| 245 | thymine-dna | 2 |
| 246 | tljn-treated | 1 |
| 247 | to-do | 1 |
| 248 | tobacco-deprived | 2 |
| 249 | top-five | 3 |
| 250 | treatment/wait | 4 |
| 251 | treatment/waiting | 3 |
| 252 | trfm/legs | 1 |
| 253 | trinucleotide | 19 |
| 254 | trp225cys | 1 |
| 255 | tumor-involved | 3 |
| 256 | unreleased | 2 |
| 257 | ureteroureteral | 1 |
| 258 | uro-check | 1 |
| 259 | v-leiden | 1 |
| 260 | v210i | 1 |
| 261 | vcug-documented | 1 |
| 262 | vg-treated | 1 |
| 263 | wait | 485 |
| 264 | waiting | 1,941 |
| 265 | xl-499 | 3 |
| 266 | ~2-4 | 1 |
| 267 | ~5.7 | 1 |
| 268 | ±5-point | 1 |
| 269 | δrpos | 1 |
| 270 | ∼200-h | 1 |
| 1 | hpv16+ | 1 |
| 2 | alad1-1 | 2 |
| 3 | gmfad8-1 | 1 |
| 4 | b1b1 | 29 |
| 5 | hla-dr1 | 1 |
| 6 | shown.t1 | 1 |
| 7 | gstm1/gstt1 | 5 |
| 8 | alad1-2/2-2 | 3 |
| 9 | gsta1-1/a2-2 | 1 |
| 10 | 1.4-2 | 1 |
| 11 | h2/h2 | 3 |
| 12 | ptv2 | 9 |
| 13 | 2.6-4.3 | 1 |
| 14 | 22q13 | 1 |
| 15 | deltactb3 | 3 |
| 16 | me3 | 2 |
| 17 | f2/f3 | 1 |
| 18 | ~2-4 | 1 |
| 19 | 4.0-6.4 | 1 |
| 20 | apoe-4/4 | 1 |
| 21 | non-apoe4 | 3 |
| 22 | group,5 | 1 |
| 23 | 1.6-15 | 1 |
| 24 | 0266 | 1 |
| 25 | 6,766 | 2 |
| 26 | ~5.7 | 1 |
| 27 | 1.3-87 | 1 |
| 28 | 1.3–2.8 | 1 |
| 29 | 1·7-1·8 | 1 |
| 30 | 1.26-9 | 1 |
| 31 | xl-499 | 3 |
| 32 | s727a | 1 |
| 33 | neopetrosia | 1 |
| 34 | formamidopyrimidine-dna | 1 |
| 35 | thymine-dna | 2 |
| 36 | epifisa | 1 |
| 37 | adra2b | 5 |
| 38 | secb | 3 |
| 39 | 12.2-mb | 1 |
| 40 | 9.04-mb | 1 |
| 41 | 12.5-mb | 1 |
| 42 | 6-mb | 1 |
| 43 | 3.17-mb | 1 |
| 44 | 9.29-mb | 1 |
| 45 | 2.76mb | 1 |
| 46 | f788c | 1 |
| 47 | alpha-cardiac | 2 |
| 48 | brassicaceae-specific | 1 |
| 49 | hypomorphic | 16 |
| 50 | nonisotopic | 4 |
| 51 | nonmicroalbuminuric | 1 |
| 52 | early-symptomatic | 2 |
| 53 | deacetylation-mimetic | 1 |
| 54 | phosphomimetic | 9 |
| 55 | homozygotic | 10 |
| 56 | heterozygotic | 5 |
| 57 | non-sclerotic | 2 |
| 58 | fibropolycystic | 1 |
| 59 | e/d | 8 |
| 60 | ag551d | 1 |
| 61 | 9c-induced | 1 |
| 62 | mlv-induced | 1 |
| 63 | azole-bridged | 1 |
| 64 | her2-nonamplified | 2 |
| 65 | dna-test-verified | 1 |
| 66 | bank-classified | 1 |
| 67 | inked | 6 |
| 68 | sod1-linked | 1 |
| 69 | genotype-confirmed | 2 |
| 70 | normally-dimensioned | 3 |
| 71 | manured | 1 |
| 72 | rochester-based | 1 |
| 73 | unreleased | 2 |
| 74 | diffusion-sensitised | 1 |
| 75 | colposcopy-diagnosed | 3 |
| 76 | space-heated | 1 |
| 77 | 5-asa-treated | 2 |
| 78 | vg-treated | 1 |
| 79 | formononetin-treated | 1 |
| 80 | tljn-treated | 1 |
| 81 | anthracycline/taxane-pretreated | 2 |
| 82 | cytokine-pretreated | 2 |
| 83 | sod-1-mediated | 2 |
| 84 | sod1-mediated | 1 |
| 85 | sod1-related | 1 |
| 86 | separation-related | 1 |
| 87 | bmimcl-impregnated | 1 |
| 88 | gel-coated | 5 |
| 89 | deaerated | 6 |
| 90 | randomly-generated | 1 |
| 91 | runx1-mutated | 1 |
| 92 | n/f-mutated | 1 |
| 93 | cardiomyocyte-restricted | 1 |
| 94 | odor-baited | 1 |
| 95 | renal-limited | 2 |
| 96 | non-inherited | 3 |
| 97 | vcug-documented | 1 |
| 98 | methide-derived | 1 |
| 99 | tobacco-deprived | 2 |
| 100 | tumor-involved | 3 |
| 101 | capsaicin-desensitized | 2 |
| 102 | single-amino-acid | 1 |
| 103 | 51-week-old | 1 |
| 104 | k650e | 2 |
| 105 | banned-substance | 1 |
| 106 | 72-nucleotide | 1 |
| 107 | 15-nucleotide | 1 |
| 108 | trinucleotide | 19 |
| 109 | brain-wide | 1 |
| 110 | drug-free | 195 |
| 111 | gap-free | 6 |
| 112 | defect-free | 11 |
| 113 | high/average | 2 |
| 114 | non-ligatable | 1 |
| 115 | -muscle | 1 |
| 116 | non-t-allele | 1 |
| 117 | centriole | 9 |
| 118 | 2-volume | 1 |
| 119 | crane | 7 |
| 120 | brca1-gene | 2 |
| 121 | guanine-adenine-adenine | 2 |
| 122 | cementum/dentine | 1 |
| 123 | ci-type | 3 |
| 124 | controlled-temperature | 1 |
| 125 | nine-base | 1 |
| 126 | one-base | 1 |
| 127 | mis-sense | 1 |
| 128 | poly-course | 3 |
| 129 | sandcrete | 1 |
| 130 | homozygote | 87 |
| 131 | heterozygote | 90 |
| 132 | top-five | 3 |
| 133 | quasi-comprehensive | 1 |
| 134 | tetrahydrobiopterin-responsive | 6 |
| 135 | phenotype-negative | 1 |
| 136 | cancer-negative | 1 |
| 137 | myofilament-negative | 5 |
| 138 | egfr-sensitive | 2 |
| 139 | her2-positive/hr-positive | 1 |
| 140 | red-fluorescent-positive | 1 |
| 141 | myofilament-positive | 5 |
| 142 | close/positive | 1 |
| 143 | tecdf | 2 |
| 144 | non-lof | 1 |
| 145 | 6a-g-g | 1 |
| 146 | 894gg | 1 |
| 147 | phospho-mimicking | 2 |
| 148 | late-talking | 1 |
| 149 | body-conforming | 2 |
| 150 | methylthio-containing | 1 |
| 151 | 'shopping | 2 |
| 152 | rasping | 5 |
| 153 | coagulation-monitoring | 1 |
| 154 | nonrelapsing | 1 |
| 155 | drm-causing | 1 |
| 156 | mutation-causing | 1 |
| 157 | acid-accumulating | 1 |
| 158 | waiting | 1,941 |
| 159 | 'waiting | 7 |
| 160 | post-waiting | 2 |
| 161 | cbt/waiting | 1 |
| 162 | treatment/waiting | 3 |
| 163 | co-eluting | 6 |
| 164 | individual-varying | 1 |
| 165 | lys/arg | 1 |
| 166 | ∼200-h | 1 |
| 167 | 10.6-h | 1 |
| 168 | q61h | 1 |
| 169 | talairach | 3 |
| 170 | v210i | 1 |
| 171 | avaii | 8 |
| 172 | uro-check | 1 |
| 173 | low-risk/intermediate-1-risk | 3 |
| 174 | low-/int-1-risk | 1 |
| 175 | prohibitive-risk | 2 |
| 176 | chemoantibiotical | 1 |
| 177 | 'non-renal | 1 |
| 178 | teminal | 1 |
| 179 | terminal | 1,635 |
| 180 | 5-bromo-2-deoxyuridine/terminal | 1 |
| 181 | cementodentinal | 1 |
| 182 | ureteroureteral | 1 |
| 183 | luminal-basal | 1 |
| 184 | charge-reversal | 1 |
| 185 | glu526val | 1 |
| 186 | p.a87_g92del | 1 |
| 187 | n596del | 1 |
| 188 | kiupel | 10 |
| 189 | attil | 4 |
| 190 | -cycloart-24-en-3β,22,26-triol | 1 |
| 191 | n-heptyl | 1 |
| 192 | t613m | 1 |
| 193 | 1-cm | 50 |
| 194 | 2-cm | 42 |
| 195 | 3-cm | 45 |
| 196 | sdrm | 1 |
| 197 | dentin/cementum | 3 |
| 198 | d202n | 3 |
| 199 | posteromedian | 1 |
| 200 | v-leiden | 1 |
| 201 | snoezelen | 40 |
| 202 | paternal-origin | 1 |
| 203 | 12.5-min | 1 |
| 204 | papionin | 1 |
| 205 | gln27gln | 3 |
| 206 | low-expression | 10 |
| 207 | rapid-breakdown | 1 |
| 208 | laco | 1 |
| 209 | to-do | 1 |
| 210 | l461p | 1 |
| 211 | 2-bp | 3 |
| 212 | 13-bp | 1 |
| 213 | 1.8kbp | 1 |
| 214 | g380r | 4 |
| 215 | non-muscular | 2 |
| 216 | rccr | 1 |
| 217 | r-carrier | 1 |
| 218 | radner | 10 |
| 219 | tesla/meter | 1 |
| 220 | first-encounter | 2 |
| 221 | core-promoter | 2 |
| 222 | 15q26.2→qter | 1 |
| 223 | 7-letter | 2 |
| 224 | superior-to-inferior | 1 |
| 225 | electron-poor | 11 |
| 226 | françois-victor | 1 |
| 227 | trfm/legs | 1 |
| 228 | p.tyr859his | 1 |
| 229 | nonsens | 1 |
| 230 | ins/ins | 2 |
| 231 | δrpos | 1 |
| 232 | low-stress | 8 |
| 233 | hemizygous | 41 |
| 234 | homozygous | 974 |
| 235 | heterozygous | 1,090 |
| 236 | hetrozygous | 1 |
| 237 | proestrous | 5 |
| 238 | trp225cys | 1 |
| 239 | p453t | 1 |
| 240 | wait | 485 |
| 241 | treatment/wait | 4 |
| 242 | glucocorticoid-resistant | 9 |
| 243 | post-adjuvant | 4 |
| 244 | caulescent | 1 |
| 245 | acaulescent | 1 |
| 246 | prevalent/incident | 1 |
| 247 | cell-cycle-dependent | 5 |
| 248 | pancreatic-insufficient | 1 |
| 249 | mixing/placement | 1 |
| 250 | consultation/treatment | 1 |
| 251 | three-solvent | 1 |
| 252 | ±5-point | 1 |
| 253 | 10-percentage-point | 1 |
| 254 | question-prompt | 1 |
| 255 | enzymun-test | 2 |
| 256 | ctv-ptv | 5 |
| 257 | gtv-ptv | 2 |
| 258 | brachymyrmex | 1 |
| 259 | coherex | 3 |
| 260 | mcnpx | 2 |
| 261 | 14.5-day | 1 |
| 262 | 25.8-day | 1 |
| 263 | emerinopathy | 1 |
| 264 | glu180gly | 1 |
| 265 | formularly | 1 |
| 266 | multi-copy | 6 |
| 267 | serotype-respiratory | 1 |
| 268 | cytarabine-refractory | 1 |
| 269 | heterozygousity | 1 |
| 270 | hmz | 13 |